Raymond James Financial »

Silverback Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 756k 10.05
2025-06-30 $12M 673k 17.45
2025-03-31 $8.9M 707k 12.58
2024-12-31 $6.6M 623k 10.55